Fibrosis and Inflammatory Markers and Long-Term Risk of Peripheral Artery Disease: The ARIC Study.

Arteriosclerosis, Thrombosis, and Vascular Biology
Ning DingKunihiro Matsushita

Abstract

Inflammatory markers, such as hs-CRP (high-sensitivity C-reactive protein), have been reported to be related to peripheral artery disease (PAD). Galectin-3, a biomarker of fibrosis, has been linked to vascular remodeling and atherogenesis. However, its prospective association with incident PAD is unknown; as is the influence of inflammation on the association between galectin-3 and PAD. Approach and Results: In 9851 Atherosclerosis Risk in Communities Study participants free of PAD at baseline (1996-1998), we quantified the association of galactin-3 and hs-CRP with incident PAD (hospitalizations with PAD diagnosis [International Classification of Diseases-Ninth Revision: 440.2-440.4] or leg revascularization [eg, International Classification of Diseases-Ninth Revision: 38.18]) as well as its severe form, critical limb ischemia (PAD cases with resting pain, ulcer, gangrene, or leg amputation) using Cox models. Over a median follow-up of 17.4 years, there were 316 cases of PAD including 119 critical limb ischemia cases. Log-transformed galectin-3 was associated with incident PAD (adjusted hazard ratio, 1.17 [1.05-1.31] per 1 SD increment) and critical limb ischemia (1.25 [1.05-1.49] per 1 SD increment). The association was slight...Continue Reading

References

Jan 12, 2007·Journal of the American Society of Nephrology : JASN·Keattiyoat WattanakitBeth D Weatherley
Dec 22, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Marianna PapaspyridonosDavid R Greaves
Aug 9, 2008·Vascular Medicine·Alan T HirschBeth A Virnig
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Jul 15, 2009·Immunological Reviews·Neil C Henderson, Tariq Sethi
Oct 7, 2009·Thrombosis and Haemostasis·Aaron R FolsomMary Cushman
Aug 17, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·Peter Libby
Nov 3, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·Laurent CalvierNatalia López-Andrés
Aug 7, 2014·Journal of the American Heart Association·Julio Madrigal-MatuteJose Luis Martin-Ventura
Feb 2, 2015·Journal of Vascular Surgery·UNKNOWN Society for Vascular Surgery Lower Extremity Guidelines Writing GroupUNKNOWN Society for Vascular Surgery
Dec 20, 2015·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jing ChenUNKNOWN CRIC Study Investigators
Jan 27, 2016·Circulation·UNKNOWN Writing Group MembersUNKNOWN Stroke Statistics Subcommittee
Mar 5, 2016·Journal of the American College of Cardiology·Peter LibbyFilip K Swirski
May 15, 2016·Journal of the American Heart Association·John W McEvoyElizabeth Selvin
May 5, 2017·International Journal of Molecular Sciences·Isabel Fort-GallifaJorge Joven
Sep 4, 2017·Kidney International·Casey M RebholzJosef Coresh
Sep 25, 2017·American Heart Journal·Oluwaseun E FashanuAaron R Folsom
Nov 21, 2017·Research and Practice in Thrombosis and Haemostasis·Oluwaseun E FashanuAaron R Folsom
Mar 27, 2018·European Heart Journal·Arjun Majithia, Deepak L Bhatt
Jul 28, 2019·Journal of the American College of Cardiology·Ning DingKunihiro Matsushita

❮ Previous
Next ❯

Citations

Dec 9, 2020·International Journal of Molecular Sciences·Valeria BlandaGiuliana Fortunato
Apr 4, 2021·International Journal of Molecular Sciences·Goren Saenz-PipaonCarmen Roncal
Jun 11, 2021·Circulation Research·Aaron W Aday, Kunihiro Matsushita
Aug 5, 2021·VASA. Zeitschrift für Gefässkrankheiten·Xiaoming JiaVijay Nambi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.